Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

870273C

Avanti

18:1 Biotinyl Cap PE

Avanti Research™ - A Croda Brand 870273C

Sinonimo/i:

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C57H102N4O11PNaS
Numero CAS:
384835-51-2
Peso molecolare:
1105.47
Numero MDL:
MFCD22495346
Codice UNSPSC:
12352211
NACRES:
NA.25

Stato

liquid

Confezionamento

pkg of 1 × 2.5 mL (870273C-25mg)
pkg of 2 × 4 mL (870273C-200mg)

Produttore/marchio commerciale

Avanti Research™ - A Croda Brand 870273C

Concentrazione

10 mg/mL (870273C-25mg)
25 mg/mL (870273C-200mg)

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Stringa SMILE

[H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]

InChI

1S/C57H103N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-41-54(64)69-46-49(72-55(65)42-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-71-73(67,68)70-45-44-59-53(63)39-32-31-37-43-58-52(62)40-36-35-38-51-56-50(48-74-51)60-57(66)61-56;/h17-20,49-51,56H,3-16,21-48H2,1-2H3,(H,58,62)(H,59,63)(H,67,68)(H2,60,61,66);/q;+1/p-1/b19-17-,20-18-;/t49-,50+,51+,56+;/m1./s1
VQSGNVZURNOPBT-XEAQQBNDSA-M

Descrizione generale

18:1 Biotinyl Cap PE, also known as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) or DOPE-B-Cap, belongs to a class of head group modified functionalized lipids.

Applicazioni

18:1 Biotinyl Cap PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) has been used in preparation of liposomes and large unilamellar vesicles (LUV).

Confezionamento

5 mL Clear Glass Sealed Ampule (870273C-200mg)
5 mL Clear Glass Sealed Ampule (870273C-25mg)

Note legali

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Comunemente ordinati con questo prodotto

N° Catalogo
Descrizione
Determinazione del prezzo

Pittogrammi

Skull and crossbonesHealth hazard
GHS06,GHS08

Avvertenze

Danger

Classi di pericolo

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3

Organi bersaglio

Central nervous system, Liver,Kidney

Codice della classe di stoccaggio

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 6

1 of 6

DSPE-PEG(2000) Biotin Avanti Research™ - A Croda Brand 880129C

Avanti

880129C

DSPE-PEG(2000) Biotin

16:0-18:1 PC Avanti Research™ - A Croda Brand

Avanti

850457C

16:0-18:1 PC

18:1 (Δ9-Cis) PE (DOPE) Avanti Research™ - A Croda Brand

Avanti

850725C

18:1 (Δ9-Cis) PE (DOPE)

18:1 PS (DOPS) Avanti Research™ - A Croda Brand

Avanti

840035P

18:1 PS (DOPS)

Syringe (1000 μL) Avanti Research™ - A Croda Brand

Avanti

610017

Syringe (1000 μL)

16:0-18:1 PC Avanti Research™ - A Croda Brand

Avanti

850457P

16:0-18:1 PC

Hideyo Takatsuki et al.
Nanotechnology, 22(24), 245101-245101 (2011-04-22)
The potential of using actin bundles for the transport of liposomes and single cells across myosin-coated surfaces is investigated. Compared to that observed with filamentous actin, the liposome transport using actin bundles was more linear in nature and able to
David K Y Zhang et al.
Nature protocols, 15(3), 773-798 (2020-01-15)
Synthetic antigen-presenting cells (APCs) are used to mediate scalable ex vivo T-cell expansion for adoptive cell therapy. Recently, we developed APC-mimetic scaffolds (APC-ms), which present signals to T cells in a physiological manner to mediate rapid and controlled T-cell expansion.
Yanqi Yu et al.
ACS nano (2018-11-14)
Understanding the binding of nanoparticles to receptors on biomembranes is critical to the development and screening of therapeutic materials. A prevailing understanding is that multivalent ligand-receptor binding leads to slower and confined translational motion of nanoparticles. In contrast, we report
Michael Estl et al.
International journal of molecular sciences, 21(7) (2020-04-08)
Cytotoxic T lymphocytes (CTL) are key players of the adaptive immune system that target tumors and infected cells. A central step to that is the formation of a cell-cell contact zone between the CTL and its target called an immune
Florian Schlosser et al.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1661), 20140028-20140028 (2014-12-24)
Cells are sensitive to mechanical cues from their environment and at the same time generate and transmit forces to their surroundings. To test quantitatively forces generated by cells not attached to a substrate, we used a dual optical trap to
Visualizza tutti i documenti correlati

Global Trade Item Number

SKUGTIN
870273C-200MG
870273C-25MG4061837668074

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.